Nomad Power Solutions (NMAD) Research & Development (2010 - 2026)
Nomad Power Solutions (NMAD) recorded Research & Development of $62,250 in Q2 2026, up 2.6% from $60,648 a year earlier.
Powered by 
Analysis
Nomad Power Solutions (NMAD) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, Nomad Power Solutions' Research & Development came in at $225,712 as of Jun 30, 2026, down 58.9% year-over-year; for FY2025, it came in at $254,919, down 64.9% from FY2024.
- Annual Research & Development has declined for four straight years, with a five-year compound annual growth rate of -26.9% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $726,232 in FY2024 (-19.1%), $898,100 in FY2023 (-33.4%), $1.35 million in FY2022 (-22.3%) and $1.74 million in FY2021 (+41.9%).
- The Q2 2026 figure is the highest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development rose in three of the last seven quarters, with an average decline of 4.5%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 279.7% in Q4 2021, against a decline of 86.0% in Q3 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Nomad Power Solutions | 60.44 Mn | 61.51 Mn | - | 62,250.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,250.00 |
| Dec 31, 2025 | 52,118.00 |
| Sep 30, 2025 | 50,696.00 |
| Jun 30, 2025 | 60,648.00 |
| Mar 31, 2025 | 91,457.00 |
| Dec 31, 2024 | 34,830.00 |
| Sep 30, 2024 | 361,630.00 |
| Jun 30, 2024 | 210,708.00 |
| Mar 31, 2024 | 119,064.00 |
| Dec 31, 2023 | 149,071.00 |
| Sep 30, 2023 | 132,487.00 |
| Jun 30, 2023 | 427,457.00 |
| Mar 31, 2023 | 189,085.00 |
| Dec 31, 2022 | 453,620.00 |
| Sep 30, 2022 | 272,388.00 |
| Jun 30, 2022 | 164,810.00 |
| Mar 31, 2022 | 458,450.00 |
| Dec 31, 2021 | 803,654.00 |
| Sep 30, 2021 | 227,181.00 |
| Jun 30, 2021 | 262,415.00 |
API Access
Nomad Power Solutions Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NMAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NMAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NMAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();